Sponsor intelligence · OTHER
Clinical trials sponsored by
Dana-Farber Cancer Institute.
Real, source-linked trial activity for Dana-Farber Cancer Institute: 4 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 22, 2026. Source-linked, daily-refreshed.
PHASE2 2EARLY_PHASE1 1NA 1
Newest Dana-Farber Cancer Institute trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | Imlunestrant/Abemaciclib/Selinexor in Ovarian and Endometrial | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 7d ago | Bladder Preservation or Cystectomy for MIBC | EARLY_Ph 1 | ACTIVE_NOT_RECRUITING | ↗ |
| 22d ago | Pedi-STAR: Surface Target Antibody-drug Conjugate (ADC) Antigen Expres | NA | NOT_YET_RECRUITING | ↗ |
| 54d ago | RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Re | Ph 2 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Dana-Farber Cancer Institute (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.